Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Adult
Animals
Antigens, CD
/ immunology
B7-H1 Antigen
/ metabolism
CD8-Positive T-Lymphocytes
/ immunology
Cornea
/ virology
Epitopes, T-Lymphocyte
/ immunology
Female
HLA Antigens
/ metabolism
HLA-A2 Antigen
/ immunology
Herpes Simplex Virus Vaccines
/ immunology
Herpesvirus 1, Human
/ immunology
Histocompatibility Antigens
/ metabolism
Histocompatibility Antigens Class II
/ metabolism
Humans
Immunization
/ methods
Male
Middle Aged
Programmed Cell Death 1 Receptor
/ immunology
Rabbits
Trigeminal Ganglion
/ virology
Vaccination
/ methods
Virus Shedding
/ immunology
Lymphocyte Activation Gene 3 Protein
CD8+ T cell
HSV-1
LAG-3
PD-1
disease
herpes
ocular
protection
rabbit
vaccine
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
15 09 2019
15 09 2019
Historique:
received:
16
05
2019
accepted:
14
06
2019
pubmed:
21
6
2019
medline:
8
7
2020
entrez:
21
6
2019
Statut:
epublish
Résumé
Chronic viruses such as herpes simplex virus 1 (HSV-1) evade the hosts' immune system by inducing the exhaustion of antiviral T cells. In the present study, we found that exhausted HSV-specific CD8
Identifiants
pubmed: 31217250
pii: JVI.00827-19
doi: 10.1128/JVI.00827-19
pmc: PMC6714801
pii:
doi:
Substances chimiques
Antigens, CD
0
B7-H1 Antigen
0
CD274 protein, human
0
Epitopes, T-Lymphocyte
0
HLA Antigens
0
HLA-A2 Antigen
0
Herpes Simplex Virus Vaccines
0
Histocompatibility Antigens
0
Histocompatibility Antigens Class II
0
Programmed Cell Death 1 Receptor
0
Lymphocyte Activation Gene 3 Protein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R41 AI138764
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026103
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143348
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158060
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019896
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150091
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI143326
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024618
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI110902
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI147499
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
J Virol. 1999 Nov;73(11):9669-72
pubmed: 10516082
Virology. 2000 Mar 1;268(1):17-28
pubmed: 10683323
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):978-83
pubmed: 11773630
J Virol. 2002 Aug;76(16):8003-10
pubmed: 12134005
J Exp Med. 2003 Aug 4;198(3):513-20
pubmed: 12900525
J Virol. 2004 Jun;78(11):5883-90
pubmed: 15140986
J Virol. 2006 Jun;80(11):5509-15
pubmed: 16699031
J Immunol. 2006 Dec 1;177(11):7510-4
pubmed: 17114418
J Virol. 2007 Aug;81(15):8157-64
pubmed: 17522198
Immunity. 2007 Oct;27(4):670-84
pubmed: 17950003
J Immunol. 2008 Jan 1;180(1):426-37
pubmed: 18097044
J Virol. 2008 Dec;82(23):11792-802
pubmed: 18799581
Science. 2008 Oct 10;322(5899):268-71
pubmed: 18845757
Nat Immunol. 2009 Jan;10(1):29-37
pubmed: 19043418
J Virol. 2009 Mar;83(5):2246-54
pubmed: 19091870
Mucosal Immunol. 2009 Mar;2(2):129-143
pubmed: 19129756
J Exp Med. 2009 Feb 16;206(2):359-70
pubmed: 19153243
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8623-8
pubmed: 19433785
Expert Rev Vaccines. 2009 Aug;8(8):1023-35
pubmed: 19627185
J Immunol. 2010 Jan 1;184(1):277-86
pubmed: 19949087
J Immunol. 2010 Mar 1;184(5):2561-71
pubmed: 20124097
J Virol. 2010 Dec;84(23):12315-24
pubmed: 20861248
J Virol. 2011 May;85(9):4184-97
pubmed: 21307196
J Virol. 2011 Sep;85(17):9127-38
pubmed: 21715478
Vaccine. 2011 Aug 11;29(35):5824-36
pubmed: 21718746
J Neurovirol. 2011 Dec;17(6):528-34
pubmed: 22161682
J Immunol. 2012 Mar 1;188(5):2173-8
pubmed: 22271651
J Virol. 2012 Apr;86(8):4358-69
pubmed: 22318137
J Virol. 2012 Apr;86(8):4328-39
pubmed: 22318154
Viral Immunol. 2012 Jun;25(3):204-15
pubmed: 22512280
J Immunol. 2013 Jun 15;190(12):6277-86
pubmed: 23656736
J Immunol. 2013 Sep 1;191(5):2258-65
pubmed: 23878317
J Immunol. 2013 Nov 15;191(10):5124-38
pubmed: 24101547
Hum Vaccin Immunother. 2014;10(4):945-63
pubmed: 24499824
Hum Immunol. 2014 Aug;75(8):715-29
pubmed: 24798939
Virology. 2014 Sep;464-465:296-311
pubmed: 25108380
J Immunol. 2015 Mar 1;194(5):2232-48
pubmed: 25617474
Curr Eye Res. 2016;41(3):284-91
pubmed: 25859798
J Virol. 2015 Jul;89(13):6619-32
pubmed: 25878105
J Neurovirol. 2015 Oct;21(5):508-17
pubmed: 26002839
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4013-28
pubmed: 26098469
Curr Eye Res. 2016 Jun;41(6):747-56
pubmed: 26398722
Cornea. 2016 Jan;35(1):81-8
pubmed: 26555580
J Virol. 2016 Mar 28;90(8):3913-3928
pubmed: 26842468
J Leukoc Biol. 2016 Aug;100(2):275-90
pubmed: 27256570
J Immunol. 2017 Jul 1;199(1):186-203
pubmed: 28539429
J Virol. 2018 Mar 28;92(8):
pubmed: 29437976
J Immunol. 2018 Apr 15;200(8):2915-2926
pubmed: 29549178
Exp Mol Med. 2018 May 22;50(5):66
pubmed: 29789565
J Virol. 2018 Jul 31;92(16):
pubmed: 29875240
J Virol. 2018 Jul 31;92(16):
pubmed: 29899087
J Immunol. 2018 Sep 1;201(5):1522-1535
pubmed: 30045971
Immunol Rev. 2018 Sep;285(1):113-133
pubmed: 30129205
Front Immunol. 2018 Aug 31;9:1909
pubmed: 30233564
Front Immunol. 2018 Sep 10;9:2041
pubmed: 30250471
J Virol. 2019 Feb 5;93(4):
pubmed: 30487281
Front Immunol. 2018 Dec 17;9:2922
pubmed: 30619285
J Virol. 2019 Apr 17;93(9):
pubmed: 30787156
J Virol. 2019 Jun 14;93(13):
pubmed: 30971470
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9969-9978
pubmed: 31036644
Immunogenetics. 1994;39(3):213-7
pubmed: 7506235
Eur J Immunol. 1995 Sep;25(9):2718-21
pubmed: 7589152
Eur J Immunol. 1994 Dec;24(12):3216-21
pubmed: 7805750
Eur J Immunol. 1996 May;26(5):1180-6
pubmed: 8647185
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5744-9
pubmed: 9159144
Virology. 1998 Dec 5;252(1):200-9
pubmed: 9875329